Mage Biotechnologies

Mage Biotechnologies is a holding company active in the fields of longevity and regenerative medicine. Our core areas of expertise are in stem-cell-based and exosome-based technologies. We undertake our business activities through several subsidiaries: Lipocube https://lipocube.com/ Lipocube specializes in the development of advanced medical devices that enable the extraction and processing of autologous adipose-based stem cells. Recure https://morphiya.com/ Recure develops, produces and markets cosmetics, supplements, and injectables featuring our proprietary Hybrid Exosomes (Hybrosomes™) technology that promote tissue regeneration and rejuvenation. London Regenerative Institute https://london-regenerative.com/ LRI provides diagnostics, treatments, and clinical services that help individuals live healthier and longer lives. Coming Soon: Exocube: Exocube will introduce medical devices for the extraction and processing of autologous exosomes, bringing yet another dimension to regenerative medicine. At Mage Biotechnologies, we are dedicated to pushing the boundaries of science and technology to deliver transformative solutions that foster longevity and well-being. Follow us to keep informed on our journey of innovation, and stay tuned for what's on the horizon.